The importance of source and purity the Salmonella-Escherichia coli reverse mutation assays, Anthraquinone (AQ) (9,10-anthracenedione) is used to enhance the L5178Y mouse lymphoma forward mutation assay, for the efficiency of the Kraft Process for the production of paper, inducing chromosomal aberrations, polyploidy or endothus reducing the demand for trees to be cut down (Cofrancesco, reduplication in Chinese hamster ovary cells, and in the 1992). AQ is the active ingredient in the most effective and in vivo mouse micronucleus assay. Further, a previous 18 non-harmful bird repellent used, for example, for keeping birds month bioassay conducted with AQ administered to male from airport runways or areas where they would conflict with and female B6C3F 1 and (C57BL/6⍥AKR)F 1 mice reported the human population (Ballinger and Price, 1996; Cummings no induction of cancer. Thus, it was somewhat unexpected et al., 1997; Ballinger et al., 1998; Dolbeer et al., 1998). that in a long-term study conducted by the National
the aqueous and organic phases, contaminants are easily recently completed a cancer bioassay with AQ showing that it exhibited weak to modest carcinogenic activity (NTP, 1999) .
Purified NTP AQ-OX Component Concentration a
The material employed in that bioassay was from the oxidation AQ 99%
process, AQ-OX, and contained an unidentified peak by GC 9-NA ND e analysis at a level of 0.12% (Battelle, 1993; NTP, 1999 et National Cancer Institute, 1987) . AQ is negative in the Syrian hamster embryo (SHE) cell transformation assay a GC-MS analyses were conducted to identify impurities using the conditions (Kerckaert et al., 1996) . AQ is also not mutagenic in a line of cancer (Innes et al., 1969) . In that study, AQ composition concern in environmental samples. Analyses were done using the conditions and looking for the target toxic compounds specified in these standard was confirmed by infrared spectroscopy, gas chromatography procedures.
and thin-layer chromatography. No contaminants were reported d Not detected (ND) at a limit of detection of Ͻ50 p.p.m. (Innes et al., 1969) .
e Not detected (ND) at a limit of detection of Ͻ5 p.p.m.
Thus, it was somewhat unexpected when the NTP reported that AQ induced a weak to modest increase in tumors in the It is clear that samples of technical grade AQ can vary kidney and bladder of male and female F344/N rats and a widely in how they are produced, and the types and amounts strong increase in the livers of male and female B6C3F 1 mice of impurities. Another purpose of these studies was to deter- (NTP, 1999) . In contrast to the numerous papers documenting mine the mutagenic activity of the actual material used in the a lack of AQ mutagenic activity noted above, two papers NTP bioassay and to contrast that with other preparations of reported that AQ was mutagenic in the Ames Salmonella AQ. A sample of the archived NTP AQ-OX was generously mutagenicity assay. The pattern of activity of AQ reported provided by the NTP. The activity of this material was was, however, unusual in that mutagenic activity was seen contrasted in the Ames Salmonella mutagenicity assay with without metabolic activation, and that addition of an S9 purified NTP AQ-OX as well as samples of AQ-FC and metabolic activation system reduced or eliminated the response AQ-DA. In addition, results from several additional genotoxic- (Liberman et al., 1982; Zeiger et al., 1988) . The chemical ity assays are reported using the AQ-DA material. structure of AQ does not suggest that the parent compound would be a DNA reactive mutagen. Therefore, it appeared that Materials and methods a mutagenic contaminant was present in the positive Ames Chemicals test samples that was either directly mutagenic or could be A sample of the AQ-OX powder employed in the NTP 2-year toxicology and activated by bacterial metabolism. Similarly, there is one report carcinogenesis studies (NTP, 1999) In fact, the problem of contamination of AQ-OX with report stated that the sample had been analyzed by the NTP and was found nitroanthracenes producing a mutagenic preparation has been to be~99% AQ and noted an impurity at a concentration of 0.12% (Battelle, well documented (US EPA, 1977; ICI, 1978a ICI, , 1978b a NTP AQ-OX contains 9-NA at a level of 1200 p.p.m. This column shows the calculated amount of this contaminant on the plate. Since AQ is not mutagenic, the mutagenic activity can be ascribed to the 9-NA and any other contaminants that might have been present. Since 9-NA was the major contaminant identified with analytical studies, and as a first approximation, mutagenic activity has been assumed to arise from the 9-NA. Nevertheless, the same issues and conclusions hold even if mutagenic activity was to be shown to arise from several different contaminants. b Judged as a positive response. Criteria for a positive response are an increasing dose-response curve with at least one response equal to or greater than twice the mean vehicle control for tester strains TA98, TA100 and WP2uvrA and/or at least three times the tester strains TA1535 and TA1537. c Positive controls without S9: TA98 1.0 µg 2-nitrofluorene; TA100 and TA1535 2.0 µg sodium azide; TA1537 2.0 µg ICR-191; WPuvrA 1.0 µg 4-nitroquinoline-N-oxide. d Positive controls with S9: TA98 2.5 µg B[a]P; TA100, TA1535 and TA1537 2.5 µg 2-aminoanthracene; WpuvrA 25 µg 2-aminoanthracene.
presented here. High quality control standards and analytical verification L5178Y thymidine kinase (TK)ϩ/-mouse lymphoma forward mutation assay indicated that these samples were very uniform. These samples were designated A sample of AQ-DA was submitted to Covance Laboratories (Vienna, VA) as AQ-DA.
to test for mutagenic activity in the L5178Y TKϩ/-mouse lymphoma forward Analytical techniques including high-performance liquid chromatography mutation assay. Industry accepted standard protocols and published procedures (HPLC) and GC-MS were performed by DCV Group (Wilmington, DE) and were followed in compliance with Good Laboratory Practice regulations Covance Laboratories (Leesburg, VA) to verify that the main component in (Amacher et al., 1980; Clive et al., 1987) . The objective of the assay was to all preparations was AQ, that purification did not alter the parent compound evaluate the ability of AQ to induce forward mutations at the TK locus in the and to identify potential contaminants (Table I) . GC-MS analysis was mouse lymphoma L5178Y cell line. The test article formed a suspension in conducted to identify impurities. US EPA Methods 610, 625 and 8270 in the dimethylsulfoxide at concentrations Ͼ1.56 mg/kg and was insoluble in medium Code of Federal Register 40 identify 16 PAH and 72 additional toxic or above~25 µg/ml. Assays were run with and without a rat liver S9 metabolic carcinogenic substances of concern in environmental samples. Analyses were activation system. Range-finding studies showed AQ to be non-toxic at done using the conditions and looking for the target toxic compounds specified nominal doses up to 500 µg/ml with and without metabolic activation. The in these standard procedures. Quantitation of contaminants was based on testing limit for the mutation assays was set at 50 µg/ml, which is about twice HPLC analysis.
the solubility limit in medium. Two independent assays were conducted each with and without metabolic activation. The criterion for a positive response Bacterial mutagenicity assays is induction of a mutation frequency that is at least two times that of the Samples NTP AQ-OX, purified NTP AQ-OX, AQ-FC and AQ-DA were control mutant frequency for that given experiment. Colony sizing was not submitted to Covance Laboratories (Vienna, VA) to test for mutagenic activity done because no positive responses were observed with AQ. in the Salmonella-Escherichia coli/Mammalian-Microsome Reverse Mutation Assay with a confirmatory assay. Industry accepted standard protocols and Chromosomal aberration induction in Chinese hamster ovary (CHO) cells published procedures were followed in compliance with Good Laboratory A sample of AQ-DA was submitted to Covance Laboratories (Vienna, VA) Practice regulations (Ames et al., 1975; Brusick et al., 1980; Maron and to test for the ability to induce chromosomal aberrations in CHO cells with Ames; 1983). The assay tested for the ability to induce reverse mutations at and without metabolic activation. Industry accepted standard protocols and the histidine locus in the genome of specific Salmonella typhimurium tester published procedures were followed in compliance with Good Laboratory strains (Ames test), and the tryptophan locus in an E.coli tester strain both in Practice regulations (Evans, 1962) . A dose range-finding study was conducted the presence and absence of an exogenous metabolic activation system (Ames to select experimental doses. Solubility considerations determined the highest et al., 1975; Brusick et al., 1980; Maron and Ames; . The activation dose to be 50 µg/ml. Replicate cultures of CHO cells were incubated with up system was a microsomal enzyme preparation derived from Aroclor-induced to 50 µg/ml AQ-DA with and without metabolic activation, with a 20.0 h rat liver (S9). Dose levels were based on a toxicity range-finding study. The harvest in an initial trial and with 20.0 and 44.0 harvests in the confirmatory top doses demonstrated test article precipitate on the plates. No appreciable trials. No visual signs of cytotoxicity were observed in the cultures analyzed. toxicity was observed with any of the samples. The experiments were repeated A test article was considered positive for inducing chromosomal aberrations independently to confirm initial results.
if a significant increase was observed compared to controls at a level of P Ͻ 0.01 Criteria for a positive response were at least a 2-fold increase in the mean
In vivo bone marrow mouse micronucleus assay revertants per plate of at least one tester strain over the mean revertants per plate of the appropriate vehicle control for tester strains TA98, TA100
A sample of AQ-DA was submitted to Covance Laboratories (Vienna, VA) for evaluation in the in vivo mouse micronucleus assay. The objective of this and WP2uvrA and/or at least a 3-fold increase for tester strains TA1535 and TA1537.
whole animal assay was to evaluate the ability of AQ-DA to induce micronuclei 0 1 4 Ϯ 3 9 3 Ϯ 9 1 3 Ϯ 3 9 Ϯ 1 1 8 Ϯ 2 30 11 Ϯ 4 8 9 Ϯ 6 1 3 Ϯ 1 6 Ϯ 3 1 7 Ϯ 6 60 12 Ϯ 3 9 2 Ϯ 11 9 Ϯ 3 5 Ϯ 2 1 9 Ϯ 6 125 14 Ϯ 3 9 4 Ϯ 11 10 Ϯ 3 5 Ϯ 3 1 6 Ϯ 3 250 17 Ϯ 6 9 3 Ϯ 8 1 2 Ϯ 6 6 Ϯ 1 1 7 Ϯ 8 500 16 Ϯ 5 107 Ϯ 7 1 0 Ϯ 1 9 Ϯ 5 1 3 Ϯ 3 1000 14 Ϯ 6 9 6 Ϯ 12 10 Ϯ 2 7 Ϯ 2 1 7 Ϯ 2 2000 14 Ϯ 4 9 8 Ϯ 5 1 2 Ϯ 2 6 Ϯ 4 1 4 Ϯ 6 pos. con. a Criteria for a positive response are an increasing dose-response curve with at least one response equal to or greater than twice the mean vehicle control for tester strains TA98, TA100 and WP2uvrA and/or at least three times the tester strains TA1535 and TA1537. b Positive controls without S9: TA98 1.0 µg 2-nitrofluorene; TA100 and TA1535 2.0 µg sodium azide; TA1537 2.0 µg ICR-191; WPuvrA 1.0 µg 4-nitroquinoline-N-oxide. c Positive controls with S9: TA98 2.5 µg B[a]P; TA100, TA1535 and TA1537 2.5 µg 2-aminoanthracene; WpuvrA 25 µg 2-aminoanthracene.
in bone marrow polychromatic erythrocytes (PCE) of Crl:CD-1 (ICR) BR gavage at up to 5000 mg/kg. Based on lack of significant toxicity, 5000 mg/ kg was selected as the highest dose for the micronucleus studies. In the mice. Industry accepted standard protocols and published procedures were followed in compliance with Good Laboratory Practice regulations (Heddle micronucleus assay, AQ-DA was suspended in corn oil and dosed by oral gavage at 1250, 2500 and 5000 mg/kg. Five males and five females were et al., 1991; Salamone and Mavournin, 1994; Schmid, 1976) . In the dose selection study the test article was suspended in corn oil and dosed by oral randomly assigned to each dose per harvest time group. Animals were killed With liver microsomes (S9) 0 1 3 Ϯ 2 7 2 Ϯ 4 9 Ϯ 4 9 Ϯ 1 2 0 Ϯ 3 30 12 Ϯ 5 7 3 Ϯ 6 1 0 Ϯ 2 9 Ϯ 1 2 3 Ϯ 3 60 12 Ϯ 6 7 7 Ϯ 8 6 Ϯ 1 9 Ϯ 1 1 9 Ϯ 6 125 14 Ϯ 5 8 5 Ϯ 13 12 Ϯ 2 1 3 Ϯ 2 2 2 Ϯ 8 250 11 Ϯ 2 8 3 Ϯ 7 1 2 Ϯ 1 9 Ϯ 3 1 9 Ϯ 1 500 15 Ϯ 7 7 7 Ϯ 9 9 Ϯ 6 8 Ϯ 1 1 8 Ϯ 4 1000 9 Ϯ 1 8 2 Ϯ 5 1 0 Ϯ 4 9 Ϯ 2 1 9 Ϯ 6 2000 9 Ϯ 1 8 2 Ϯ 5 1 0 Ϯ 4 1 1 Ϯ 4 1 6 Ϯ 8 pos. con.
191 Ϯ 21 c 582 Ϯ 22 c 519 Ϯ 31 c 126 Ϯ 25 c 301 Ϯ 12 c a Criteria for a positive response are an increasing dose-response curve with at least one response equal to or greater than twice the mean vehicle control for tester strains TA98, TA100 and WP2uvrA and/or at least three times the tester strains TA1535 and TA1537. b Positive controls without S9: TA98 1.0 µg 2-nitrofluorene; TA100 and TA1535 2.0 µg sodium azide; TA1537 2.0 µg ICR-191; WPuvrA 1.0 µg 4-nitroquinoline-N-oxide. c Positive controls with S9: TA98 2.5 µg B[a]P; TA100, TA1535 and TA1537 2.5 µg 2-aminoanthracene; WpuvrA 25 µg 2-aminoanthracene.
24, 48 and 72 h after dosing with the test article for extraction of the bone marrow. A response was judged positive if it was significantly greater than the corresponding vehicle control at a level of P Ͻ 0.01. than B[a]P and equal in potency to 2-nitrofluorene (Table II) .
d Mutagenic as judged by exceeding the minimum criterion of 228.6 for this experiment (twice the control frequency).
Neither AQ-FC nor AQ-DA showed any mutagenic activity The weak increase in polyploidy observed in these cultures was judged a statistical anomaly because the values observed are within the historical negative control data of 0-9.5% and the solvent control data of 0-10% and there was no indication of activity under any of the other exposure conditions or trials.
either with or without metabolic activation in the Ames tester polychromatic erythrocyte: normochromatic erythrocyte (PCE:NCE) ratio. AQ-DA did not induce a significant increase strains or in WP2uvrA (Tables IV and V). in micronuclei in bone marrow polychromatic erythrocytes L5178Y TK ϩ/-mouse lymphoma forward mutation assay under the conditions of this assay and is considered negative No cytotoxicity was observed in any of the trials in the L5178Y in the mouse bone marrow micronucleus test (Table VIII) . mutation assays. Mutant frequencies of treated cultures varied randomly with dose toxicity and no increases above the Discussion minimum criteria for a positive response were induced (Table Genetic toxicology VI). AQ-DA was therefore evaluated as negative with and The lack of mutagenic or genotoxic activity in a variety of without metabolic activation at the TK locus in L5178Y mouse assays in numerous laboratories indicates that AQ is not a lymphoma cells under the conditions used in this study.
DNA-reactive genotoxic carcinogen (Brown and Brown, 1976 ; Chromosomal aberration induction in CHO cells Anderson and Styles, 1978; Gibson et al., 1978 ; Salamone CHO cells were incubated with up to 50.0 µg/ml of AQ-DA et al., 1979; Sakai et al., 1985; Tikkanen et al., 1983 ; National with harvest times of 20 and 44 h (Table VII) . No significant Cancer Institute, 1987; Kerckaert et al., 1996; Durant et al., increase in cells with chromosomal aberrations, polyploidy or 1996) . Those assays are strengthened by the studies presented endoreduplication was observed at the concentrations analyzed.
here in which we report that purified NTP AQ-OX, AQ-FC AQ-DA was considered negative for inducing chromosomal and AQ-DA are negative in the expanded Ames mutagenicity aberrations in CHO cells with and without metabolic activation.
test, that AQ-DA is negative in the L5178Y mouse lymphoma In vivo bone marrow mouse micronucleus assay forward mutation assay, that AQ-DA does not induce chromosomal aberrations, polyploidy or endoreduplication in CHO In the micronucleus assay, AQ-DA was suspended in corn oil and dosed by oral gavage at 1250, 2500 and 5000 mg/kg. No cells, and that it is negative in the in vivo mouse micronucleus assay (Tables III-VIII) . bone marrow toxicity was observed as a decrease in the Nevertheless that bioassay did not show carcinogenic activity (Innes et al., 1969) . Looking at the data as a whole strongly indicates the possibility that the observed tumors in gistically to enhance the mutagenic and carcinogenic responses (Columbano et al., 1981) . The report of direct-acting genotoxic activity in two Ames
Contaminants as confounders of the cancer bioassay tests (Liberman et al., 1982; Zeiger et al., 1988) 
was unexpected
The best way to evaluate the plausibility as to whether the because the data were in conflict with so many other reports contaminant in the NTP AQ-OX produced the tumor response of negative mutagenic activity. In both of those reports the in the NTP study would be to do a potency calculation AQ was obtained from Aldrich Chemical Co. and the label based on the carcinogenic potency of the 9-NA contaminant. purity was listed as only 97% (Liberman et al., 1982; Unfortunately, no cancer data are available for 9-NA. One et al., 1988) . No analysis of the identity of the remaining 3% way to estimate potency is to extrapolate comparisons of of non-AQ material was done. The problem of contamination genotoxic potency to potential carcinogenic potency. Although with nitroanthracenes producing genotoxic activity in preparait is recognized that there are limitations to such comparisons, tions of AQ-OX has been described (US EPA, 1977; ICI, a reasonable estimate of plausibility can usually be made. 1978a, 1978b) . In fact, the NTP AQ-OX was contaminated Another way to address the plausibility question is to ask how with 1200 p.p.m. 9-NA (Table I ). The NTP AQ-OX was potent a carcinogen the contaminant would have to be in order mutagenic in strains TA98, TA100 and TA1537, while the to produce the observed response. purified NTP AQ-OX was not. The structure of AQ does not Mutagenic potency comparisons suggest direct DNA reactivity, yet the NTP AQ-OX was mutagenic without added metabolic activation. Taken together Both 9-NA and 2-nitroanthracene (2-NA) are mutagenic with these data indicate that AQ is not genotoxic, rather that the the 2-NA isomer being substantially more potent (Fu et al., NTP sample of AQ-OX contains the mutagenic contaminant 1986). 9-NA is present in the NTP AQ-OX at a level of 1200 9-NA. p.p.m. Therefore, the amount of the contaminant present on each Ames test plate is easily calculated (shown in Table II ).
Cytogenetics
Since AQ is not mutagenic, all the mutagenic activity can be The NTP report described a mouse peripheral blood ascribed to the contaminants. Table II shows that mutagenic micronuclei assay test from the 14 week range-finding study activity can be seen in strain TA98 without metabolic activation that preceded the cancer bioassay (NTP, 1999) . The tentative at a level of only 0.15 µg 9-NA per plate. As a first conclusion was that the data showed that AQ-OX exhibited approximation it is reasonable to assign this mutagenic activity weak activity in that assay. However, the doses used were up to the primary contaminant 9-NA. Accordingly, on the basis to four times the maximum tolerated dose used in the bioassay, of induced revertants per microgram in tester strain TA98, no response was seen in the female animals, and the response 9-NA with 173 revertants/µg was more potent than B[a]P with in the males was judged as positive only with a highly non-137 revertants/µg and was as potent as the 2-nitrofluorene conservative trend test. In contrast, AQ-OX was negative in a with 175 revertants/µg run concurrently as positive controls bone marrow micronucleus assay (NTP, 1999) . AQ-DA was (Table II) . also negative in a mouse bone marrow micronucleus assay in the studies reported here (Table VIII) 
and a chromosomal
Cancer potency calculations aberration assay in CHO cells (Table VII) . Taken together, the A critical question is whether it is plausible that a contaminant weight of evidence of the data indicates that AQ does not could be a significant contributor to the carcinogenic activity induce cytogenetic damage. observed in the NTP bioassay. The Handbook of Carcinogenic Cancer studies Potency and Genotoxicity Databases defines a valuable parameter to rank cancer potency, the Tumor Dose 50 (TD 50 ) The observation of a mutagenic contaminant confounds any interpretation of the NTP bioassay with AQ. A previous (Gold and Zeiger, 1997) . The TD 50 is the tumorigenic doserate for 50% of experimental animals, or the dose-rate that bioassay with males and females in two strains of mice had been conducted with AQ. That study was not done following will halve the probability of remaining tumor free at the end of a standard lifespan. For a given target site, if there are no contemporary bioassay standards and needed to be repeated. 50 for key target sites in the NTP AQ cancer study were estimated from a least squares linear fit of the tumor data dose-response curve (Gold and Zeiger, 1997; NTP, 1999) . b The theoretical TD 50 for 9-NA was calculated knowing that the percentage of contaminating 9-NA was 0.12%, and assuming that the 9-NA was responsible for inducing the all the tumors.
